ReGenerCell™ is an innovative treatment which can be used to treat acute and chronic wounds including diabetic foot ulcers and venous leg ulcers of varying size and depth.
ReGenerCell™ allows a clinician to collect specialised cells from a small sample of your healthy skin and process them for application on another area that needs healthy skin cells.
While the clinician prepares the area to be treated, the collected cells are processed into RES™ (Regenerative Epithelial Suspension™), and are then sprayed onto your wound by the clinician.
Wounds should not be treated with ReGenercell™ if there is a pre-existing infection or uncontrolled necrosis.
The ReGenerCell™ device processes your skin sample into RES™ (Regenerative Epithelial Suspension™). The device uses a proprietary enzyme formulation to process the skin cells. This enzyme formulation is used to dissociate the cells into a solution – RES™, which is then applied to the wound to regenerate natural, healthy skin.
A skin sample is a thin small shave of skin taken from an area of healthy normal skin. The sample is used to gather the cells that will be used to treat the wound. The size of the sample depends on the area that will be treated and will be calculated by your clinician.
The donor site is the area from which a sample is taken.
This generally occurs at the bedside under local anaesthetic.
A small sample of skin is collected from an area of healthy normal skin. The sample is usually around one to two centimetres square (the size and thickness of one to two postage stamps) and is also treated with the spray to help it heal properly.
While the clinician is preparing the area to be treated ensuring there is no sign of infection, the healthy skin sample is placed into the ReGenerCell™ device. The ReGenerCell™ device separates the skin cells into a suspension, allowing the clinician to spray it or drip it onto the skin. The healthy cells are applied to the wound where they grow and reconstruct healthy skin.
After the operation the treated area and donor site will be covered with a dressing. The area will initially be numb but may sting soon after the operation. This is normal and you are usually allowed to take medication to reduce any discomfort.
You should inform any healthcare professional who is looking after you and your wound that you have been treated with ReGenerCell™. After about a week (depending on the reason why you had ReGenerCell™) the dressing will be removed by your clinician. Your clinician will give you advice concerning what creams you are allowed to use, how much you can expose the treated area to the sun and what you should expect after the treatment.
ReGenerCell™ is a very safe procedure as it uses your own cells, so no specific risks are related to the procedure. After removal of all the dressings, the skin will be red and there may be some scabs. This is normal. Your clinician will give you advice concerning what creams you are allowed to use and what you should expect after the treatment.
As with any treatment, there are risks associated with ReGenerCell™ treatment. For example, you may have a reaction to the anaesthesia or you may get an infection that result in you requiring antibiotics, undergoing more treatment or getting scars. It is important that you discuss all possible outcomes with your clinician before consenting to any operation so that you are aware of all potential side effects and complications.
ReGenerCell™ should not be used on infected wounds. Patients with a known hypersensitivity (allergy) to anaesthesia, sodium lactate or the enzyme (Trypsin) should not be treated with ReGenerCell™.
It is also important that the patient is willing to comply with post-operative instructions to avoid the risk of complications.